pyrazines has been researched along with aspirin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Adamska-Dyniewska, H; Chojnacki, J; Chojnowska-Jezierska, J; Goch, JH; Kowalaczyk, L; Zydowicz, L | 1 |
| Kaliszan, R; Petrusewicz, J; Pilarski, B; Yilinkou, RG | 1 |
| Gao, BT | 1 |
| Ding, YA; Yen, MH | 1 |
| Barnett, A; Chiu, PJ; Gerhart, C; Kaminski, J; Policelli, M | 1 |
| Fukushi, H; Imura, Y; Kawamura, M; Kita, S; Moriya, N; Nishikawa, K; Sugihara, H; Terashita, Z | 1 |
| Reddy, BS | 1 |
| Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
| Nicholson, NS; Parlow, JJ; Salyers, AK; South, MS; Suleymanov, OD; Szalony, JA; Wood, RS | 1 |
| Dahdaleh, FS; Musallam, KM; Shamseddine, AI; Taher, AT | 1 |
| Hatzidaki, E; Karagiannaki, A; Papandreou, CN; Patrikidou, A; Stathakis, NE; Tsapakidis, K; Voutsadakis, IA | 1 |
| Du, Z; Fan, M; Gu, W; Jiao, Y; Kim, JG; Nosrat, CA; Pavicevic, Z; Pfeffer, LM; Rao, SK; Rosebush, M; Samant, S | 1 |
| Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B | 1 |
| He, L; Lee, J; Mendell-Harary, J; Tao, B; Walker, J; Wickremasingha, P; Wight, D | 1 |
| Bagheri, M; Ghasemi, F; Mirzaei, H; Tabatabae Far, MA | 1 |
| Parhofer, KG | 1 |
| Hao, Y; He, X; Sun, CC; Wang, C; Wang, K; Zhao, X | 1 |
| Abouhajar, A; Alcock, L; Bigirumurame, T; Bradley, P; Brown, L; Campbell, I; Del Din, S; Faitg, J; Falkous, G; Gorman, GS; Lakey, R; McFarland, R; Newman, J; Rochester, L; Ryan, V; Smith, H; Steel, A; Stefanetti, RJ; Su, H; Taylor, RW; Thomas, NJP; Tuppen, H; Vincent, AE; Warren, C; Watson, G | 1 |
3 review(s) available for pyrazines and aspirin
| Article | Year |
|---|---|
Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents.
Topics: Allyl Compounds; Anethole Trithione; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arachidonic Acids; Aspirin; Colon; Colonic Neoplasms; Dinoprostone; Disulfides; Eflornithine; Food, Fortified; Ibuprofen; Intestinal Mucosa; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Piroxicam; Pyrazines; Thiones; Thiophenes | 1997 |
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Topics: Arsenic Trioxide; Arsenicals; Aspirin; Boronic Acids; Bortezomib; Heparin, Low-Molecular-Weight; Humans; Incidence; Lenalidomide; Multiple Myeloma; Oxides; Pyrazines; Thalidomide; Venous Thromboembolism | 2009 |
Topics: Aspirin; Humans; Pyrazines; Randomized Controlled Trials as Topic; Thrombosis; Treatment Outcome; Venous Thromboembolism | 2020 |
2 trial(s) available for pyrazines and aspirin
| Article | Year |
|---|---|
[Side effects following ingestion of non-steroid anti-inflammatory agents].
Topics: Adult; Aged; Anti-Inflammatory Agents; Aspirin; Clinical Trials as Topic; Hallucinations; Humans; Indomethacin; Joint Diseases; Mefenamic Acid; Middle Aged; Placebos; Pyrazines | 1975 |
Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
Topics: Adenosine Triphosphate; Adult; Aspirin; Child; Fatigue; Humans; Mitochondrial Myopathies; Muscular Diseases; Pyrazines; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
13 other study(ies) available for pyrazines and aspirin
| Article | Year |
|---|---|
Antithrombotic activity of a new pyrazine derivative determined by the mouse antithrombotic assay.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Embolization, Therapeutic; Fibrinolytic Agents; Humans; Indomethacin; Lung; Male; Mice; Platelet Aggregation; Pyrazines | 1992 |
[The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
Topics: Aged; Aged, 80 and over; Aspirin; Betahistine; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Pyridines; Vasodilator Agents | 1989 |
Effects of tetramethylpyrazine on platelet aggregation.
Topics: Animals; Aspirin; Collagen; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Inbred Strains | 1987 |
Gastric cytoprotective properties of SCH 32651, a novel antiulcer agent.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Cysteamine; Drug Evaluation, Preclinical; Duodenal Ulcer; Ethanol; Gastric Mucosa; Imidazoles; Indomethacin; Male; Pyrazines; Rats; Reserpine; Stomach Ulcer; Stress, Physiological | 1984 |
Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
Topics: Alprostadil; Animals; Arginine; Aspirin; Clopidogrel; Dogs; Fibrinolytic Agents; Guanidines; Guinea Pigs; Humans; Macaca fascicularis; Male; Pipecolic Acids; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Sulfonamides; Ticlopidine | 1996 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |
Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment.
Topics: Aminobenzoates; Animals; Anticoagulants; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Drug Combinations; Factor VIIa; Hemorrhage; Macaca fascicularis; Male; Platelet Aggregation Inhibitors; Prothrombin Time; Pyrazines; Thromboplastin; Warfarin; Whole Blood Coagulation Time | 2004 |
Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.
Topics: Apoptosis; Aspirin; bcl-Associated Death Protein; Blotting, Western; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Down-Regulation; Drug Synergism; Humans; NF-kappa B; Proto-Oncogene Proteins c-akt; Pyrazines | 2010 |
Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Biomarkers; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Profiling; Humans; Inflammation; Interleukin-8; Microarray Analysis; Mouth Neoplasms; NF-kappa B; Pyrazines; RNA, Small Interfering | 2010 |
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2011 |
Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
Topics: Adolescent; Adult; Allylamine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticonvulsants; Antihypertensive Agents; Area Under Curve; Aspirin; Atenolol; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Phenytoin; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Thiazolidinediones; Tissue Distribution; Triazoles; Young Adult | 2014 |
Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug.
Topics: Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Oxaliplatin; Pyrazines; Pyridines; Wnt Signaling Pathway | 2020 |
Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization.
Topics: Aspirin; Biological Availability; Crystallization; Pyrazines; Solubility | 2022 |